Updated safety and efficacy results from the phase I study of either LBL-007 (an anti-LAG-3 antibody) in combination with toripalimab (an anti-PD-1 antibody) or LBL-007 in combination with toripalimab and axitinib in patients with advanced melanoma

被引：0
|
作者：
Bai, Xue
Li, Mei
Chen, Yu
Si, Lu
Chen, Jing
Pu, Xingxiang
Cheng, Ying
Zou, Zhengyun
Zhao, Shiwei
Li, Tao
Cai, Shengli
Guo, Jun
机构：
[1] Peking Univ Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ Beijing, Dept Renal Canc & Melanoma, Beijing, Peoples R China
[2] Sichuan Univ, West China Hosp, Chengdu, Peoples R China
[3] Fujian Med Univ, Fujian Canc Hosp, Dept Med Oncol, Clin Oncol Sch, Fuzhou, Peoples R China
[4] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Canc Ctr, Wuhan, Peoples R China
[5] Cent South Univ, Hunan Canc Hosp, Affiliated Canc Hosp, Xiangya Med Sch, Changsha, Peoples R China
[6] Jilin Canc Hosp, Dept Med Thorac Oncol, Changchun, Peoples R China
[7] Nanjing Univ, Drum Tower Hosp, Med Sch, Comprehens Canc Ctr, Nanjing, Peoples R China
[8] Nanjing Univ, Clin Canc Inst, Nanjing, Peoples R China
[9] Nanjing Leads Biolabs Co Ltd, Nanjing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9541
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Interim results of a phase 1b/2 study of ADG126 (a masked anti-CTLA-4 SAFEbody®) monotherapy and in combination with toripalimab (an anti-PD-1 antibody) in patients (pts) with advanced/metastatic solid tumors
    Ariyapperuma, Mihitha
    Park, John J.
    Khattak, Adnan
    Richardson, Gary
    Hamid, Anis
    Morris, Michelle
    Tolcher, Anthony W.
    Goh, Boon Cher
    Lam, Justina
    Chmielowski, Bartosz
    She, Kristine
    Zhang, Yanyan
    Li, Ai
    Zheng, Songmao
    Liu, Guizhong
    Zhu, Lvyu
    Wang, Hongyan
    Cui, Xiaoxing
    Luo, Peter
    Zha, Jiping
    CANCER RESEARCH, 2023, 83 (08)
  • [32] A PHASE 1B/2 STUDY OF A NOVEL ANTI-CTLA-4 NEOBODYTM ADG116 MONOTHERAPY AND IN COMBINATION WITH TORIPALIMAB (TORI; ANTI-PD-1 ANTIBODY) IN PATIENTS WITH ADVANCED/METASTATIC SOLID TUMORS
    Park, John
    Hsien, Matthew
    Richardson, Gary
    Tolcher, Anthony
    Chon, Hong Jae
    Shin, Sang Joon
    Lim, Ho Yeong
    Hamid, Anis
    Li, Daneng
    Shi, Kristine
    Zheng, Songmao
    Liu, Guizhong
    Li, Ai
    Zhu, Lvyu
    Dai, Ruby
    Peng, Wei
    Lowe, Dana
    Luo, Peter
    Zha, Jiping
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A785 - A785
  • [33] A first-in-human phase I dose escalation of YH001, an anti-CTLA-4 monoclonal antibody (mAb) in combination with toripalimab (anti-PD-1 mAb) in patients with advanced solid tumors.
    Ganju, Vinod
    Cooper, Adam
    Gao, Bo
    Wilkinson, Kate
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [34] IBI110 (anti-LAG-3 mAb) as a single agent or in combination with sintilimab (anti-PD-1 mAb) in patients with advanced solid tumors: Updated results from the phase Ia/Ib dose-escalation study
    Xu, Nong
    Mao, Chenyu
    Qian, Jiong
    Zheng, Yulong
    Jiang, Haiping
    Gao, Yuan
    Xiao, Cheng
    Xiong, Anwen
    Li, Wei
    He, Yayi
    Ren, Shengxiang
    Wang, Lei
    Yu, Jia
    Zhu, Jun
    Liu, Ying
    Zhou, Caicun
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [35] A phase I/II study of KD6001, a novel fully human anti-CTLA4 IgG1 monoclonal antibody, in combination with toripalimab in patients with advanced melanoma
    Li, Siming
    Duan, Rong
    Tang, Bixia
    Sheng, Xinan
    Si, Lu
    Cui, Chuanliang
    Mao, Lili
    Wang, Xuan
    Lian, Bin
    Wei, Xiaoting
    Yan, Xieqiao
    Li, Juan
    Zhou, Li
    Xu, Huayan
    Li, Caili
    Cai, Zeling
    Zhang, Chi
    Wang, Fangfang
    Chi, Zhihong
    Guo, Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [36] The Efficacy and Safety of Surufatinib Combined with Anti PD-1 Antibody Toripalimab in Neoadjuvant Treatment of Locally Advanced Differentiated Thyroid Cancer: A Phase II Study
    Chen, Jia-ying
    Huang, Nai-si
    Wei, Wen-jun
    Hu, Jia-qian
    Cao, Yi-ming
    Shen, Qiang
    Lu, Zhong-wu
    Wang, Yu-long
    Wang, Yu
    Ji, Qing-hai
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (12) : 7172 - 7180
  • [37] Phase I/Ib Clinical Trial of Sabatolimab, an Anti-TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti-PD-1 Antibody, in Advanced Solid Tumors
    Curigliano, Giuseppe
    Gelderblom, Hans
    Mach, Nicolas
    Doi, Toshihiko
    Tai, David
    Forde, Patrick M.
    Sarantopoulos, John
    Bedard, Philippe L.
    Lin, Chia-Chi
    Hodi, F. Stephen
    Wilgenhof, Sofie
    Santoro, Armando
    Sabatos-Peyton, Catherine A.
    Longmire, Tyler A.
    Xyrafas, Alexandros
    Sun, Haiying
    Gutzwiller, Sabine
    Manenti, Luigi
    Naing, Aung
    CLINICAL CANCER RESEARCH, 2021, 27 (13) : 3620 - 3629
  • [38] The Efficacy and Safety of Surufatinib Combined with Anti PD-1 Antibody Toripalimab in Neoadjuvant Treatment of Locally Advanced Differentiated Thyroid Cancer: A Phase II Study
    Jia-ying Chen
    Nai-si Huang
    Wen-jun Wei
    Jia-qian Hu
    Yi-ming Cao
    Qiang Shen
    Zhong-wu Lu
    Yu-long Wang
    Yu Wang
    Qing-hai Ji
    Annals of Surgical Oncology, 2023, 30 : 7172 - 7180
  • [39] Clinical activity of fianlimab (REGN3767), a human anti-LAG-3 monoclonal antibody, combined with cemiplimab (anti-PD-1) in patients (pts) with advanced melanoma.
    Hamid, Omid
    Wang, Ding
    Kim, Tae Min
    Kim, Sang-We
    Lakhani, Nehal J.
    Johnson, Melissa Lynne
    Groisberg, Roman
    Papadopoulos, Kyriakos P.
    Kaczmar, John M.
    Middleton, Mark R.
    Spira, Alexander I.
    Williamson, Stephen K.
    Rabinowits, Guilherme
    Gutierrez, Rodolfo
    McKean, Meredith
    Chen, Shuquan
    Cassidy, James
    Mani, Jayakumar
    Sims, Tasha Nicholle
    Kroog, Glenn
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [40] Anti-PD-1 antibody cetrelimab (JNJ-63723283) in patients with advanced cancers: Updated phase I/II study results.
    Rutkowski, Piotr
    Felip, Enriqueta
    Moreno, Victor
    Perez, Jose Manuel Trigo
    Calvo, Aitana
    Kowalski, Dariusz
    Cortinovis, Diego
    Lee, James J.
    Manikhas, George
    Plummer, Elizabeth Ruth
    Maio, Michele
    Ascierto, Paolo Antonio
    Vladimirov, Vladimir Ivanovich
    Gaffney, Dana
    Li, Lilian Y.
    Bae, Kyounghwa
    Greger, James G.
    Shin, Chu Ri
    Xie, Hong
    Calvo, Emiliano
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
12345